<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Since 1989, 22 patients with persistent <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (PAPS) associated with <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriage</z:e> (defined as three or more <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e>) were treated with fish oil, equivalent to 5.1 g eicosapentaenoic acid (<z:chebi fb="113" ids="28364">EPA</z:chebi>) and <z:chebi fb="0" ids="36005">docosahexaenoic acid</z:chebi> (DHA) at a ratio of 1.5 EPA to DHA </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty-two patients had 23 pregnancies (one patient had two pregnancies) over a period of 3 years </plain></SENT>
<SENT sid="2" pm="."><plain>There was only one intrauterine fetal <z:hpo ids='HP_0011420'>death</z:hpo> at the 27th week associated with pre-<z:hpo ids='HP_0100601'>eclampsia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Twenty-one pregnancies, 19 of which ended after the 37th week, produced a baby </plain></SENT>
<SENT sid="4" pm="."><plain>Two pregnancies ended with cesarean section for pre-<z:hpo ids='HP_0100601'>eclampsia</z:hpo> at 30th and 35th week of gestation and one is ongoing at 32nd week </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> babies are well </plain></SENT>
<SENT sid="6" pm="."><plain>The weight at birth of babies delivered at term was always &gt; 2500 g </plain></SENT>
<SENT sid="7" pm="."><plain>These encouraging results favour a therapeutic role, without any adverse reaction, of fish oil to prevent <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriage</z:e> in PAPS </plain></SENT>
</text></document>